A groundbreaking shift in our drug policy has occurred, as the authorities allow the use of psilocybin hallucinogens for therapeutic applications. Before this, these substances were heavily restricted, but a increasing body of evidence suggests they potentially offer relief for psychological illnesses like depression. This development represents a